A LIGHTFUL nanomedicine overcomes EGFR-mediated drug resistance for enhanced tyrosine-kinase-inhibitor-based hepatocellular carcinoma therapy
Ke Yi, Huimin Kong, Chunxiong Zheng, Chenya Zhuo, Yuanyuan Jin, Qingguo Zhong, Rachel L. Mintz, Enguo Ju, Haixia Wang, Shixian Lv, Yeh‐Hsing Lao, Yu Tao, Mingqiang Li
Topics & Concepts
Cancer researchCRISPRTyrosine-kinase inhibitorHepatocellular carcinomaGenetic enhancementCombination therapyPharmacologyMedicineBiologyCancerInternal medicineGeneBiochemistryRNA Interference and Gene DeliveryCRISPR and Genetic EngineeringAdvanced biosensing and bioanalysis techniques